21
views
0
recommends
+1 Recommend
1 collections
    0
    shares

      International Journal of Nanomedicine (submit here)

      This international, peer-reviewed Open Access journal by Dove Medical Press focuses on the application of nanotechnology in diagnostics, therapeutics, and drug delivery systems throughout the biomedical field. Sign up for email alerts here.

      105,621 Monthly downloads/views I 7.033 Impact Factor I 10.9 CiteScore I 1.22 Source Normalized Impact per Paper (SNIP) I 1.032 Scimago Journal & Country Rank (SJR)

      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Nanofibrous Scaffolds Containing Hydroxyapatite and Microfluidic-Prepared Polyamidoamin/BMP-2 Plasmid Dendriplexes for Bone Tissue Engineering Applications

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Objective

          The aim of this study is to fabricate functional scaffolds to gene delivery bone morphogenetic protein-2 (BMP-2) plasmid for bone formation in bone tissue engineering.

          Methods

          Dendriplexes (DPs) of generation 4 polyamidoamin (G4-PAMAM)/BMP-2 plasmid were prepared through microfluidic (MF) platform. The physiochemical properties and toxicity of DPs were evaluated by DLS, AFM, FESEM and MTT assay. In order to create a suitable environment for stem cell growth and differentiation, poly-l-lactic acid (PLLA) and poly-l-lactic acid/poly (ethylene oxide) (PLLA/PEO) scaffolds containing hydroxyapatite nanoparticles (HA) and DPs were fabricated by the electrospinning method. The osteogenic potency of the scaffolds on human adipose tissue-derived mesenchymal stem cells (hASCs) was investigated.

          Results

          The results revealed that tuning the physical properties of DPs by adjusting flow parameters in microfluidic platform can easily improve the cell viability compared to conventional bulk mixing method. Also, the result showed that the presence of HA and DPs in PLLA/PEO scaffold enhanced alkaline phosphatase (ALP) activity and increased the amount of deposited Ca, as well as, related to osteogenesis gen markers.

          Conclusion

          This study indicated that on using the MF platform in preparation of DPs and loading them along with HA in PLLA/PEO scaffold, the osteogenic differentiation of hASCs could be tuned.

          Most cited references34

          • Record: found
          • Abstract: found
          • Article: not found

          Control and detection of chemical reactions in microfluidic systems.

          Recent years have seen considerable progress in the development of microfabricated systems for use in the chemical and biological sciences. Much development has been driven by a need to perform rapid measurements on small sample volumes. However, at a more primary level, interest in miniaturized analytical systems has been stimulated by the fact that physical processes can be more easily controlled and harnessed when instrumental dimensions are reduced to the micrometre scale. Such systems define new operational paradigms and provide predictions about how molecular synthesis might be revolutionized in the fields of high-throughput synthesis and chemical production.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Poly (amidoamine) (PAMAM) dendrimer mediated delivery of drug and pDNA/siRNA for cancer therapy

            Poly (amidoamine) (PAMAM) dendrimers are well-defined, highly branched macromolecules with numerous active amine groups on the surface. Because of their unique properties, PAMAM dendrimers have steadily grown in popularity in drug delivery, gene therapy, medical imaging and diagnostic application. This review focuses on the recent developments on the application in PAMAM dendrimers as effective carriers for drug and gene (pDNA, siRNA) delivery in cancer therapy, including: a) PAMAM for anticancer drug delivery; b) PAMAM and gene therapy; c) PAMAM used in overcoming tumor multidrug resistance; d) PAMAM used for hybrid nanoparticles; and e) PAMAM linked or loaded in other nanoparticles.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              Polyethylenimine-based nanocarriers in co-delivery of drug and gene: a developing horizon

              ABSTRACT The meaning of gene therapy is the delivery of DNA or RNA to cells for the treatment or prevention of genetic disorders. The success rate of gene therapy depends on the progression and safe gene delivery system. The vectors available for gene therapy are divided into viral and non-viral systems. Viral vectors cause higher transmission efficiency and long gene expression, but they have major problems, such as immunogenicity, carcinogenicity, the inability to transfer large size genes and high costs. Non-viral gene transfer vectors have attracted more attention because they exhibit less toxicity and the ability to transfer large size genes. However, the clinical application of non-viral methods still faces some limitations, including low transmission efficiency and poor gene expression. In recent years, numerous methods and gene-carriers have been developed to improve gene transfer efficiency. The use of Polyethylenimine (PEI) based transfer of collaboration may create a new way of treating diseases and the combination of chemotherapy and gene therapy. The purpose of this paper is to introduce the PEI as an appropriate vector for the effective gene delivery.
                Bookmark

                Author and article information

                Journal
                Int J Nanomedicine
                Int J Nanomedicine
                IJN
                intjnano
                International Journal of Nanomedicine
                Dove
                1176-9114
                1178-2013
                21 April 2020
                2020
                : 15
                : 2633-2646
                Affiliations
                [1 ]Department of Pharmaceutical Biomaterials, Faculty of Pharmacy, Tehran University of Medical Sciences , Tehran, Iran
                [2 ]Department of Biotechnology, University of Tehran , Tehran, Iran
                [3 ]Department of Biomedical Engineering, Amirkabir University of Technology , Tehran, Iran
                [4 ]Department of Cell and Developmental Biology, School of Biological Sciences, College of Science, University of Tehran , Tehran, Iran
                [5 ]Department of Pharmaceutics, Faculty of Pharmacy, Tehran University of Medical Sciences , Tehran, Iran
                [6 ]Department of Microbiology, School of Biology, College of Science, University of Tehran , Tehran, Iran
                [7 ]Department of Resin and Additives, Institute for Color Science and Technology , Tehran, Iran
                [8 ]Department of Physics, University of Tehran , Tehran, Iran
                [9 ]Department of Medicinal Chemistry, Faculty of Pharmacy, Tehran University of Medical Sciences , Tehran, Iran
                Author notes
                Correspondence: Hamid Akbari Javar Department of Pharmaceutics, Faculty of Pharmacy, Tehran University of Medical Sciences , P.O. Box: 1417614411, Tehran, IranTel +98 2164122205 Email akbarijo@tums.ac.ir
                Author information
                http://orcid.org/0000-0003-2543-8618
                http://orcid.org/0000-0002-5983-3598
                http://orcid.org/0000-0002-9514-2575
                http://orcid.org/0000-0003-2614-3088
                http://orcid.org/0000-0002-0758-4710
                Article
                244416
                10.2147/IJN.S244416
                7183354
                32368045
                1239656b-36b4-4038-a37d-3c24f5ac2f77
                © 2020 Doosti-Telgerd et al.

                This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.php).

                History
                : 01 January 2020
                : 01 April 2020
                Page count
                Figures: 9, Tables: 1, References: 39, Pages: 14
                Categories
                Original Research

                Molecular medicine
                microfluidic,dendriplex,nanofibrous scaffolds,bone tissue engineering
                Molecular medicine
                microfluidic, dendriplex, nanofibrous scaffolds, bone tissue engineering

                Comments

                Comment on this article